Advertisement

Views and practices of renal nurses in monitoring residual renal function for haemodialysis patients

      Abstract

      Background

      Haemodialysis is a treatment option offered to patients with end-stage kidney disease. Patients who commence haemodialysis will often have some degree of residual renal function (RRF) with a continued urine output between treatment schedules. Efforts to preserve the remaining RRF can offer several health benefits for haemodialysis patients.

      Aim

      To explore the views and practices of Australian and New Zealand renal nurses in monitoring RRF of haemodialysis patients between treatment schedules.

      Methods

      This study used a cross-sectional research design. Participants were recruited through distribution of an electronic survey. Quantitative descriptive data were analysed and presented as frequencies, percentages, medians, and interquartile ranges. Reporting of this study adhered to the STROBE checklist.

      Findings

      Fifty-five renal nurses completed the survey. Of these, 10 (18.2%) always, 41 (74.5%) sometimes, and 3 (5.5%) never discussed urine output with patients before commencing haemodialysis. Eight (14.5%) participants indicated ultrafiltration goals did not include calculations based on urine output between treatment schedules.

      Discussion

      The monitoring of RRF provides several health benefits for patients requiring maintenance haemodialysis. Practice differences in fluid assessment policies did not always account for self-reported urine output. The inclusion of an estimated daily urine output between treatment schedules has the potential to lower ultrafiltration goals minimising the risk of intradialytic hypotension.

      Conclusion

      The survival and quality of life for patients requiring maintenance haemodialysis can be improved by the preservation of RRF. Findings from this study suggest practice differences occur among renal nurses in the monitoring of urine output.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Collegian
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. ANZDATA Registry. (2020). 43rd Report. Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia. Available at http://www.anzdata.org.au [Accessed 30 December 2020].

        • Ashby D.
        • N B.
        • Burton J.
        • Corbett R.
        • Davenport A.
        • Farrington K.
        • et al.
        Renal association clinical practice guideline on haemodialysis.
        BMC Nephrology. 2019; 20: 379https://doi.org/10.1186/s12882-019-1527-3
        • Australian Institute of Health and Welfare
        Chronic kidney disease prevalence among Australian adults over time.
        Australian Government, Canberra2018 (Available at https://www.aihw.gov.au/getmedia/cbfc53e4-c6fc-4a8e-9a7f-e5dfa38ae10c/aihw-cdk-6.pdf.aspx?inline=true [Accessed 14 January 2021])
        • Bargman J.M.
        • Thorpe K.E.
        • Churchill D.N.
        • for the CANUSA peritoneal dialysis study group
        Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.
        Journal of the American Society of Nephrology. 2001; 12: 2158-2162
        • Bello A.K.
        • Levin N.W.
        • Tonelli M.
        • Okpechi I.G.
        • Feehally J.
        • Harris D.
        • et al.
        Assessment of global kidney health care status.
        JAMA. 2017; 317: 1864-1881https://doi.org/10.1001/jama.2017.4046
        • Campbell S.
        Fluid assessment: a competency assessment package for advanced nephrology nursing practice.
        Renal Society of Australasia Journal. 2006; 2: 41-50
        • Canaud B.
        • Chazot C.
        • Koomans J.
        • Collins A.
        Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities.
        Brazilian Journal of Nephrology. 2019; 41: 550-559https://doi.org/10.1590/2175-8239-JBN-2019-0135
        • Chen H.-C.
        • Chou C.-Y.
        • Jheng J.-S.
        • Chen I.-R.
        • Liang C.-C.
        • Wang S.-M.
        • et al.
        Loss of residual renal function is associated with vascular calcification in haemodialysis patients.
        Therapeutic Apheresis and Dialysis. 2016; 20: 27-30https://doi.org/10.1111/1744-9987.12376
        • Curran S.P.
        • Bargman J.M.
        The importance of residual renal function in peritoneal dialysis.
        Dialysis and Transplantation. 2011; : 349-355https://doi.org/10.1002/dat.20597
        • Dasgupta I.
        • Farrington K.
        • Davies S.J.
        • Davenport A.
        • Mitra S.
        UK national survey of practice patterns of fluid volume management in haemodiallysis patients: a need for evidence.
        Blood Purification. 2016; 41: 324-331https://doi.org/10.1159/000444246
        • Elm E.
        • Egger M.
        • Altman D.G.
        • Pocock S.J.
        • Gotzsche P.C.
        • Vandenbroucke J.P.
        • for the STROBE initiative
        Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies.
        BMJ. 2007; 335: 806-808
        • Fang A.
        • Lunardi L.
        • Skilton F.
        • Turner D.
        Residual renal function among patients on haemodilysis and implications for clinical practice.
        Renal Society of Australasia Journal. 2020; 16: 44-53https://doi.org/10.33235/rsaj.16.2.44-53
        • Flythe J.E.
        • Assimon M.M.
        • Overman R.A.
        Target weight achievement and ultrafiltration rate thresholds: Potential patient implications.
        BMC Nephrology. 2017; 18: 185https://doi.org/10.1186/s12882-017-0595-5
        • Flythe J.E.
        • Kimmel S.E.
        • Brunelli S.M.
        Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality.
        Kidney International. 2011; 79: 250-257https://doi.org/10.1038/ki.2010.383
        • Gunal A.I.
        • Kirciman E.
        • Guler M.
        • Yavuzkir M.
        • Celiker H.
        Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new haemodialysis patients?.
        Renal Failure. 2004; 26: 405-409https://doi.org/10.1081/JDI-120039825
        • Hecking M.
        • McCullough K.P.
        • Port F.K.
        • Bieber B.
        • Morgenstern h.
        • Yamamoto H.
        • et al.
        Self-reported urine volume in hemodialysis patients: Predictors and mortality outcomes in the international Dialysis Outcomes and Practice Patterns Study (DOPPS).
        American Journal of Kidney Diseases. 2019; 74: 425https://doi.org/10.1053/j.ajkd.2019.02.012
        • Keane D.
        • Glyde M.
        • Dasgupta I.
        • Gardiner C.
        • Lindley E.
        • Mitra S.
        • et al.
        Patient perspectives of target weight management and ultrafiltration in haemodialysis: A multi-center survey.
        BMC Nephrology. 2021; 22: 188https://doi.org/10.1186/s12882-021-02399-7
        • Kuipers J.
        • Verboom L.M.
        • Ipema K.J.R.
        • Paans W.
        • Krijnen W.P.
        • Gaillard C.A.J.M.
        • et al.
        The prevalence of intradialytic hypotension in patients on conventional hemodialysis: A systematic review with meta-analysis.
        American Journal of Nephrology. 2019; 49: 497-506https://doi.org/10.1159/000500877
        • Lee M.J.
        • Park J.T.
        • Park K.S.
        • Kwon Y.E.
        • Oh H.J.
        • Yoo T.-H.
        • et al.
        Prognostic value of residual urine volume, GFR by 24-hour urine collection, and eGFR in patients receiving dialysis.
        Clinical Journal of the American Society of Nephrology. 2017; 12: 426-434https://doi.org/10.2215/CJN.05520516
        • Lee Y.-J.
        • Okuda Y.
        • Sy J.
        • Lee Y.K.
        • Obi Y.
        • Cho S.
        • et al.
        Ultrafiltration rate, residual kidney function, and survival among patients treated with reduced-frequency hemodialysis.
        American Journal Kidney Diseases. 2020; 75: 342-350https://doi.org/10.1053/j.ajkd.2019.08.019
        • Lee Y.K.
        • Okuda Y.
        • Sy J.
        • Kim S.R.
        • Obi Y.
        • Kovesdy C.P.
        • et al.
        Ultrafiltration rate effects declines in residual kidney function in hemodialysis patients.
        American Journal of Nephrology. 2019; 50: 481-488https://doi.org/10.1159/000503918
        • Li T.
        • Wilcox C.S.
        • Lipkowitz M.S.
        • Gordon-Cappitelli J.
        • Dragoi S.
        Rationale and strategies for preserving residual kidney function in dialysis patients.
        American Journal of Nephrology. 2019; 50: 411-421https://doi.org/10.1159/000503805
        • Lim W.H.
        • Johnson D.W.
        • McDonald S.P.
        • Hawley C.
        • Clayton P.A.
        • Jose M.D.
        • et al.
        Impending challenges of the burden of end-stage kidney disease in Australia.
        Medical Journal of Australia. 2019; 211: 374-380https://doi.org/10.5694/mja2.50354
        • Lindberg M.
        • Ludvigsen M.S.
        Ultrafilration rate as a nursing-sensitive quality indicator in haemodialysiss.
        International Journal of Nursing Studies. 2012; 49: 1320-1324https://doi.org/10.1016/j.ijnurstu.2012.02.018
        • Liu Y.
        • Zou W.
        • Wu J.
        • Liu L.
        • He Q.
        Comparison between incremental and thrice-weekly haemodialysis: systematic review and meta-analysis.
        Nephrology. 2019; 24: 438-444https://doi.org/10.1111/nep.13252
        • Loutradis C.
        • Sarafidis P.A.
        • Ferro C.J.
        • Zoccali C.
        Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management.
        Nephrology Dialysis Transplantation. 2021; 36: 2182-2193https://doi.org/10.1093/ndt/gfaa183
        • Mathew A.T.
        • Fishbane S.
        • Obi Y.
        • Kalantar-Zadeh K.
        Preservation of residual kidney function in hemodialysis patients: reviving an old concept.
        Kidney International. 2016; 90: 262-271https://doi.org/10.1016/j.kint.2016.02.037
        • Mitema D.
        • Jaar B.G.
        How can we improve the quality of life of dialysis patients?.
        Seminars in Dialysis. 2016; 29: 93-102https://doi.org/10.1111/sdi.12467
        • National Health and Medical Research Council
        National Statement on Ethical Conduct in Human Research (2007) - Updated 2018.
        Commonwealth of Australia, Canberia2018 (Available from http://www.nhmrc.gov.au/about-us/publications/national-statement-ethical-conduct-human-research-2007-updated-2018. Accessed 8th January 2021)
        • New Zealand Ministry of Health
        Managing chronic kidney disease in primary care: National concensus statement.
        Ministry of Health, Wellington2015 (Available from) ([Accessed 8th January 2021])
        • Obi Y.
        • Rhee C.M.
        • Mathew A.T.
        • Shah G.
        • Streja E.
        • Brunelli S.M.
        • et al.
        Residual kidney function decline and mortality in incident hemodialysis patients.
        Journal of the American Society of Nephrology. 2016; 27: 3758-3768https://doi.org/10.1681/ASN.2015101142
        • Pecoits-Filho R.
        • Okpechi I.G.
        • Donner J.-A.
        • Harris D.C.H.
        • Aljubori H.M.
        • Bello A.K.
        • et al.
        Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes.
        Kidney International Supplements. 2020; 10: e3-e9https://doi.org/10.1016/j.kisu.2019.11.001
        • Poulsen C.G.
        • Kjaergaard K.D.
        • Peters C.D.
        • Jespersen B.
        • Jensen J.D.
        Quality of life development during initial hemodialysis therapy and association with loss of residual renal function.
        Hemodialysis International. 2017; 21: 409-421https://doi.org/10.1111/hdi.12505
      2. Renal Society of Australasia. (1999). Competency standards for the New Zealand Renal Nurse. In. Wellington, New Zealand.

        • Rodger R.S.C.
        Approach to the management of end-stage renal disease.
        Clinical Medicine. 2012; 12: 472-475
        • Sars B.
        • van der Sande F.M.
        • Kooman J.P.
        Intradialytic hypotension: mechanisms and outcome.
        Blood Purification. 2020; 49: 158-167https://doi.org/10.1159/000503776
        • Steinwandel U.
        • Gibson N.
        • Towell-Barnard M.
        • Parsons R.
        • Rippey J.
        • Rosman J.
        Measuring the prevalence of intradialytic hypotension in a satellite dialysis clinic: are we too complacement?.
        Journal of Clinical Nursing. 2018; 27: e1561-e1570https://doi.org/10.1111/jocn.14309
        • Stenberg J.
        • Lindberg M.
        • Furuland H.
        Clinical praxis for assessment of dry weight in Sweden and Denmark: a mixed-methods study.
        Hemodialysis International. 2016; 20: 111-119https://doi.org/10.1111/hdi.12336
        • Swift O.
        • Vilar E.
        • Farrington K.
        Hemodialysis.
        Medicine. 2019; 47: 596-602https://doi.org/10.1016/j.mpmed.2019.06.004
        • Termorshuizen F.
        • Korevaar J.C.
        • Dekker F.W.
        • van Manen J.G.
        • Boeschoten E.W.
        • et al.
        The relative importance of residual renal function compared with peritoneal clearnce for patient survival and quality of life: An analysis of the netherlands cooperative study on the adequacy of dialysis (Necosad)-2.
        American Journal of Kidney Diseases. 2003; 41: 1293-1302https://doi.org/10.1016/S0272-6386(03)00362-7
        • Tucker P.S.
        • Kingsley M.I.
        • Morton R.H.
        • Scanlan A.T.
        • Dalbo V.J.
        The increasing financial impact of chronic kidney disease in Australia.
        International Journal of Nephrology. 2014; (Article ID 120537)https://doi.org/10.1155/2014/120537
        • Watanabe Y.
        • Yamagata K.
        • Nishi S.
        • Hirakata H.
        • Hanafusa N.
        • et al.
        Japanese society for dialysis therapy clinical guidelines for'hemodialysis initiation for maintenance hemodialysis.
        Therapeutic Apheresis and Dialysis. 2015; 19: 93-107https://doi.org/10.1111/1744-9987.12293
        • Wong J.
        • Vilar E.
        • Davenport A.
        • Farrington K.
        Incremental haemodialysis.
        Nephrology Dialysis Transplantation. 2015; 30: 1639-1648https://doi.org/10.1093/ndt/gfv231
        • You A.S.
        • Kalantar-Zadeh K.
        • Obi Y.
        • Novoa A.
        • Peralta R.A.
        • Streja E.
        • Rhee C.M.
        Residual urine output and mortality in a prospective hemodialysis cohort.
        Kidney International Reports. 2020; 5: 643-653https://doi.org/10.1016/j.ekir.2020.02.002
        • Zhang T.
        • Gan X.-N.
        • Tang W.
        • Zou M.
        • Zhang Y.
        The status quo and prospect of transfer and shift in patients receiving hemodialysis in China.
        Frontiers of Nursing. 2019; 6: 169-174https://doi.org/10.2478/FON-2019-0028